Transmitters involved in antinociception in the spinal cord

Brain Research Bulletin

Volumn 48, Issue 2, 1999, Pages 129-141

  Fürst, Susanna ^a  

^a SEMMELWEIS UNIVERSITY OF MEDICINE   (Hungary)

Author keywords

Nociception; Receptors; Spinal cord; Transmitters

Indexed keywords

ADRENERGIC RECEPTOR STIMULATING AGENT; ALPHA 2A ADRENERGIC RECEPTOR; ALPHA 2B ADRENERGIC RECEPTOR; ANTINOCICEPTIVE AGENT; RECEPTOR SUBTYPE;

ANTINOCICEPTION; NEUROTRANSMISSION; NEUROTRANSMITTER RELEASE; NONHUMAN; PRIORITY JOURNAL; REVIEW; SPINAL ANESTHESIA; SPINAL CORD;

ANALGESIA; ANIMALS; HUMANS; NEUROTRANSMITTER AGENTS; NOCICEPTORS; PAIN; SPINAL CORD; SYNAPTIC TRANSMISSION;

EID: 0033555286     PISSN: 03619230     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0361-9230(98)00159-2     Document Type: Review

References (97)

1. Aanonsen, L. M.; Wilcox, G. L. Nociceptive action of excitatory amino acids in the mouse: Effects of spinally administered opioids, phencyclidine and sigma agonists. J. Pharmacol. Exp. Ther. 243:9-19; 1987.
2. 2-adrenoceptor agonist, reduces anesthetic requirements for patients undergoing minor gynecologic surgery. Anesthesiology 73:230-242; 1990.
3. Baber, N. S.; Dourish, C.T.; Hill, D. R. The role of CCK coerulein and CCK antagonists in nociception. Pain 39:307-328; 1989.
4. Bach, F. W. β-endorphin in the brain: A role in nociception. Acta Anaesth. Scand. 41:133-140; 1997.
5. Bagdy, G.; To, T. T. Comparison of relative potencies of i.v and i.c.v administered 8-OH-DPAT gives evidence of different sites of action for hypothermia, lower lip retraction and tail flicks. Eur. J. Pharmacol. 323:53-58; 1996.
6. Bannon, A. W.; Decker, M. W.; Holloday, M. W.; Cruzon, P.; Donnely-Roberts, D.; Puttfarcken, P. S.; Bittner, R. S.; Diaz, A.; Dickenstein, A. H.; Porsolt, R. D.; Williams, M.; Arneric, S. P. Broad spectrum, non opioid analgesic activity by selective modulation of neuronal nicotinic acetylcholine receptors. Science 279:77-81; 1998.
7. Basbaum, A. I. Anatomical substrates of pain and pain modulation and their relationship to analgesic drug action. In: Kuhar, M.; Pasternak, G., eds. Analgesic: Neurochemical behavioral and clinical perspectives. NewYork: Raven Press; 1984:97-123.
8. 1A receptors postsynaptic to serotoninergic neurones mediate spontaenous tail flicks in the rat. J. Pharmacol. Exp. Ther. 264:95-104; 1993.
9. Bevan, S.; Szolcsanyi, J. Sensory neuron-specific actions of capsaicin: Mechanism and applications. Trends Pharmacol. Sci. 11:330-333; 1990.
10. Björkman, R. Central antinociceptive effects of non-steroidal antiinflammatory drugs and paracetamol. Acta Anaesth. Scand. 39(suppl 103):7-44; 1995.
11. Buccafusco, J. J.; Shuster, L. C. Effect of intrathecal pretreatment with the neurokinin receptor antagonist CP-99994 on the expression of naloxone-precipitated morphine withdrawal symptoms. Brain Res. Bull. 43:321-326; 1997.
12. + ion permeability. Brain Res. Bull. 44:19-23; 1997.
13. Cherny, N. I.; Thaler, H. T.; Friedlander-Klar, L.; Lapin, J.; Foley, K. M.; Houde, R.; Oortenoy, R. K. Opioid responsiveness of cancer pain syndromes caused by neuropathic or nociceptive mechanisms: A combined analysis of controlled, single-dose studies. Neurology 44: 857-861; 1994.
14. Collin, E.; Frechilla, D.; Pohl, M.; Bourgoin, S.; Mauborgne, A.; Cesselin, F. Differential effects of the novel analgesic S12813-4, on the spinal release of substances P and calcitonin gene-related peptide-like materials in the rat. Naunyn-Scmiedeberg Arch. Pharmacol. 349: 387-393; 1994.
15. Crisp, T.; Stafinsky, J. L.; Hoskins, D. L.; Perni, V. C.; Uram, M.; Gordon, T. Age related changes in the spinal antinociceptive effects of DAGO, DPDPE and β-endorphin in the rat. Brain Res. 643:282-286; 1994.
16. Davis, L.; Pollock, L. J.; Stone, T. T. Visceral pain. Surg. Gynecol. Obstet. 55:418; 1932.
17. Dewey, W. L.; Snyder, J. W.; Harris, L. S.; Howes, J. F. The effects of narcotics and narcotic antagonists on the tail flick response in spinal mice. J. Pharm. Pharmacol. 21:548-555; 1969.
18. Dickenson, A. H. A cure for wind up: NMDA receptor antagonists as potential analgesics. Trends Pharmacol. Sci. 11:307-309; 1990.
19. Dickenson, A. H. NMDA-receptor antagonists: Interaction with opioids. Acta Anaesth. Scand. 41:112-115; 1997.
20. Dray, A. Mechanism of action of capsaicin-like molecules on sensory neurons. Life Sci. 51:1759-1765; 1992.
21. Dray, A.; Urban, L. New pharmacological strategies for pain relief. Annu. Rev. Pharmacol. Toxicol. 36:253-280; 1996.
22. Ferreira, S. H.; Lorenzetti, B.; Bristow, A. F.; Poole, S. Interleukin-1 beta as a potent hyperalgesic agent antagonized by a tripeptide analogue. Nature 334:698-700; 1988.
23. Fitzgerald, M. The contralateral input to the dorsal horn of the spinal cord. Brain Res. 236:275-287; 1982.
24. 2-adrenergic agonists during general anaesthesia. Anaesth. Pharmacol. Rev. 1:268-283; 1993.
25. Fleetwood-Walker, S. M.; Mitchell, R.; Hope, P. J.; El Yassir, N.; Molony, V.; Bladon, C. M. The involvement of neurokinin receptor subtypes in somatosensory processing in the superficial dorsal horn of the cat. Brain Res. 519:169-182; 1990.
26. Forman, L. J.; Tringo, L.; Sun, M. Cocaine and inhibition of nitric oxide synthesis produce opioid-mediated antinociception. Brain Res. Bull. 44:125-129; 1997.
27. Frederickson, R. C. A. Endogenous opioid peptides and relative derivatives. In: Kuhar, M.; Pasternak, G., eds. Analgesics: Neurochemical behavioral and clinical perspectives. New York: Raven Press; 1984:9-68.
28. Frederickson, R. C.; Burgis, V.; Harrell, C. E.; Edwards, J. D. Dual actions of substance P on nociception: Possible role of endogenous opioids. Science 199:1359-1362; 1978.
29. Garces, Y. I.; Rabito, S. F.; Minshall, R. D.; Sagen, J. Lack of potent antinociceptive activity by substance P antagonists CP-96,345 in the rat spinal cord. Life Sci. 52:353-360; 1993
30. Garthwaite, J. Glutamate, nitric oxide and cell-cell signalling in the nervous system. Trends Neurosci. 14:60-67; 1991.
31. Ghilardi, J. R.; Allen, C. J.; Vigna, S. R.; McVey, D. C.; Mantyh, P. W. Trigeminal and dorsal root ganglion neurons express CCK receptor binding sites in the rat, rabbit, and monkey: Possible site of opiate-CCK interactions. J. Neurosci. 12:4854-4866; 1992.
32. Gintzler, A. R.; Levy, A.; Spector, S. Antibodies as a means of isolating and characterizing biologically active substances: Presence of a non peptide, morphine like compound in the central nervous system. Proc. Natl. Acad. Sci. USA 73:2132-2136; 1976.
33. Goettl, V. M.; Larson, A. A. Activity at phencyclidine and mu opioid sites mediates the hyperalgesic and antinociceptive properties of the N-terminus of substance P in a model of visceral pain. Neuroscience 60:375-382; 1994.
34. Goldstein, A.; Barrett, R. W.; James, I. F.; Lowney, L. I.; Weitz, C. J.; Knipmeyer, L. L.; Rapoport, H. Morphine and other opiates from beef brain and adrenal. Proc. Natl. Acad. Sci. 82:5203-5207; 1985.
35. Gouarderes, C.; Jhamandas, K.; Cridland, R.; Cros, J.; Quirion, R.; Zajac, J. M. Opioid and substance P receptor adaptations in the rat spinal cord following sub-chronic intrathecal treatment with morphine and naloxone. Neuroscience 54:799-807; 1993.
36. 2A-adrenergic receptors are present in lower brainstem catecholaminergic and serotonergic neurons innervating spinal cord. Brain Res. 638:285-294; 1994.
37. Hamalainen, M. M.; Pertovaara, A. The antinociceptive action of an alpha adrenoceptro agonist in the spinal horn is due to a diect spinal action and not to activation of descending inhibition Brain Res. Bull. 37:581-587; 1995.
38. Hamon, M. D.; Collin, E.; Chantrel, D.; Verge, D.; Bourgoin, S. The contribution of monoamines and their receptors to pain control. In: Basbaum, A. I.; Besson, J., eds. Towards a new pharmacotherapy of pain. Chicester, UK: Wiley; 1991:83-102.
39. Hanks, G. W.; Forbes, K. Opioid responsiveness. Acta Anaesth. Scand. 41:154-158; 1997.
40. Harris, J. A. Using c-fos as a neural marker of pain. Brain Res. Bull. 45:1-8; 1998.
41. Haubrich, D. R.; Baizman, E. R.; Morgan, B. A.; Selens, J. K. The role of endogenous nonendorphin substances in nociception. In: Kuhar, M.; Pasternak, G., eds. Analgesics: Neurochemical behavioral and clinical perspectives. New York: Raven Press; 1984:195-234.
42. Helke, G. J.; Neil, J. J.; Massari, V. J.; Loewy, A. D. Substance P neurons project from the ventricular medulla to the intermediolateral cell column and ventral horn in the rat. Brain Res. 243:147-152; 1982.
43. Henderson, G.; Mcknight, A. T. The orphan opioid receptor and its endogeneous igand-nociceptin/orphanin FQ. Trends Pharmacol. 18: 293-300; 1997.
44. Herndon, J. L.; Glennon, R. A. Serotonin receptors, agents, and actions. In: Kozikowski, A. P., ed. Drug design for neuroscience. New York: Raven Press; 1993:167-177.
45. Herz, A., ed. Opioids I-II. Berlin: Springer Verlag; 1993.
46. Hosztafi, S.; Fürst, S. Endogenous morphine. Pharmacol. Res. 31:1-6; 1995.
47. Hoyer, D.; Clarke, D. E.; Fozard, J. R.; Hartig, P. R.; Martin, G. R.; Mylecharane, E. J.; Saxena, P. R.; Humphrey, P. P. A. International Union of Pharmacology classification of receptors for 5-HT (serotonin). Pharmacol. Rev. 46:157-203; 1994.
48. Hunt, S. P.; Pini, A.; Evan, G. Induction of c-fos-like protein in spinal cord neurons following sensory stimulation. Nature 328:632-634; 1987.
49. Jensen, T. S.; Yaksh, T. L. The antinociceptive activity of excitatory amino acids in the rat brainstem: An anatomical and pharmacological analysis. Brain Res. 569:255-267; 1992.
50. + channels are involved in the mediation of intrathecal norepinephrine or morphine induced antinociception at the spinal level: A study using EMG planimetry of flexor reflex in rats. Brain Res. Bull. 45:269-273; 1998.
51. Ko, M. L.; King, M. A.; Gordin, T. L.; Crisp, T. The effects of aging on spinal neurochemistry in the rat. Brain Res. Bull. 42:95-98; 1997.
52. Kuraishi, Y.; Nanayama, T.; Ono, H.; Minami, M.; Satoh, M. Antinociception induced in rats by intrathecal administration of antiserum against calcitonin gene related peptide. Neurosci Lett. 92:325-329; 1988.
53. Le Bars, D.; Dickenson, A. H.; Besson, J. M.; Villaneuva, L. Aspects of sensory processing through convergent neurons. In: Yaksh, T. L., ed. Spinal afferent processing. New York: Plenum Press; 1986:467-504.
54. Lewin, G. R.; Mendell, L. M. Nerve growth factor and nociception. Trends Neurosci. 16:353-358; 1993.
55. Liu, H.; Wang, H.; Sheng, M.; Jan, L. I.; Basbaum, A. I. Evidence for presynaptic NMDA autoreceptors in the spinal cord dorsal horn. Proc. Natl. Acad. Sci. USA 91:8383-8387; 1994.
56. Liu, H.; Mantyh, P. W.; Basbaum, A. I. NMDA-receptor regulation of substance P release from primary afferent nociceptors. Nature 386: 721-724; 1997.
57. Ma, L.; Cheng, Z. I.; Fan, G. H.; Cai, Y. C.; Jiang, L. Z.; Pei, G. Functional expression, activation and desensitization of opioid receptor-like receptor ORL 1 in neuroblastoma X glioma NG1088-15 hybrid cells. FEBS Lett. 403:91-94; 1997.
58. Malick, J. B.; Goldstein, J. M. Analgesic activity of substance P following intracerebral administration in rats. Life Sci. 23:835-844; 1978.
59. McGaraughty, S.; Henry, J. L. Effects of noxious hindpaw immersion on evoked and spontaneous firing of contralateral convergent dorsal horn neurons in both intact and spinalized rats. Brain Res. Bull. 43:263-267; 1997.
60. Meller, S. T.; Gebhart, G. F. Nitric oxide (NO) and nociceptive processing in the spinal cord. Pain 52:127-136; 1993.
61. 1A agonists attenuate morphine-induced antinociception in mice in a competitive-like manner. J. Pharmacol. Exp. Ther. 256:983-992; 1991.
62. 1A agonists and antagonists in rodents: Relationship to algesiometric paradigm. Behav. Brain Res. 73:69-77; 1996.
63. Picard, F.; Boucher, S.; Regoli, D.; Gitter, B. D.; Howbert, J. J.; Couture, R. Use of non peptide tachykinin receptor antagonists to substantiate the involvement of NK1 and NK2 receptors in a spinal nociceptive reflex in the rat. Eur. J. Pharmacol. 232:255-261; 1993.
64. Rang, H. P.; Bevan, S.; Dray, A. Chemical activation of nociceptive peripheral neurons. Br. Med. Bull. 47:534-548; 1991.
65. Reddy, S. V. R.; Maderdrut, J. L.; Yaksh, T. L. Spinal cord pharmacology of adrenergic agonist mediated antinociception. J. Pharmacol. Exp. Ther. 213:525-533; 1980.
66. Reinscheid, R. K.; Nothacker, H. P.; Bourson, A.; Ardati, A.; Henningsen, R. A.; Bunzow, J. R.; Grandy, D. K.; Langen, H.; Monsma Jr., F. J.; Civelli, O. Orphanin FQ: A neuropeptide that activates an opioidlike G protein-coupled receptor. Science 270: 792-794; 1995.
67. Riedl, M.; Shuster, S.; Vulchanova, L.; Wang, J.; Loh, H. H.; Eide, R. Orphanin FQ/nociceptin-immunoreactive nerve fibers paralell those containing endogenous opioids in rat spinal cord. Neuroreport 7:1369-1372; 1996.
68. Roberts, M. H. Pharmacology of putative neurotransmitters and receptors: 5-hydroxytryptamine. Prog. Brain Res. 77:329-338; 1988.
69. Rossi, G. C.; Leventhal, L.; Bolan, E.; Pasternak, G. W. Pharmacological characterization of orphanin FQ/nociceptin and its fragments. J. Pharmacol. Exp. Ther. 282:858-865; 1997.
70. Sawynok, J.; Reid, A. Interactions of descending serotonergic systems with other neurotransmitters in the modulation of nociception. Behav. Brain Res. 73:63-68; 1996.
71. Segal, J. S.; Jarvis, D. J.; Duncan, S. R.; White, P. F.; Maze, M. Clinical efficacy of oral-transdermal clonidine combinations during perioperative period. Anesthesiology 74:220-225; 1991.
72. Sershen, H.; Balla, A.; Lajtha, A.; Vizi, E. S. Characterization of nicotinic receptors involved in the release of noradrenaline from the hippocampus. Neuroscience 77:121-130; 1997.
73. Shorr, J.; Foley, K.; Spector, S. Presence of a non-peptide morphine-like compound in human cerebrospinal fluid. Life Sci. 23:2057-2062; 1978.
74. Stein, C.; Morgan, M. M.; Liebeskind, J. C. Barbiturate-induced inhibtion of a spinal nociceptive reflex: Role of GABA mechanisms and descending modulation. Brain Res. Rev. 407:307-311; 1987.
75. Tarasiuk, A.; Gibbs, L.; Kendig, J. J. Descending inhibition in neonatal rat spinal cord:Actions of pentobarbital and morphine. Brain Res. Bull. 41:39-45; 1996.
76. 3H]-noradrenaline from rat spinal cord. Brain Res. Bull. 42:129-132; 1996.
77. Urea, G.; Raigorodsky, G. Behavioral classification of excitatory amino acid receptors in mouse spinal cord. Eur. J. Pharmacol. 153: 211-220; 1988.
78. Vizi, E. S. Different temperature dependence of carrier-mediated (cytoplasmic) and stimulus-evoked (exocytotic) release of transmitter: A simple method to separate the two types of release. Neurochem. Int. 33:359-366; 1998.
79. 2-adrenoceptors. J. Phalmacol. Exp. Ther. 238:701-706; 1986.
80. Vizi, E. S.; Kiss, J. Neurochemistry and pharmacology of the major hippocampal transmitter systems: Synaptic and non-synaptic interactions. Hippocampus. 8:566-607; 1998.
81. Vizi, E. S.; Lábos, E. Nonsynaptic interactions at presynaptic level. Progr. Neurobiol. 37:145-163; 1991.
82. Vizi, E. S.; Mike, A.; Tarnawa, I. 2,3-Benzodiazepines (GYKI 52466 and analogs): Negative allosteric modulators of AMPA receptors. CNS Drug Rev. 2:91-126; 1996.
83. Vizi, E. S.; Mike, A.; Tarnawa, I. The functional study of kainate receptors - hopes and doubts. Trends Neurosci. 20:396; 1997.
84. 2A-adrenoceptor antagonists. J. Med. Chem. 30:1355-1359; 1987.
85. Winter, J.; Forbes, C. A.; Sterberg, J.; Lindsay, J. M. Nerve growth factor (NGF) regulates adult rat cultured dorsal root ganglion neuron responses to capsaicin. Neuron 1:973-981; 1988.
86. Wu, A. Y.; Kozlov, G.; Barasi, S. The actions of 5-HT1 agonists and antagonists on nociceptive processing in the rat spinal cord: Results from behavioural and electrophysiological studies. Brain Res. 661:83-90; 1994.
87. Yaksh, T. L. Direct evidence that spinal serotonin and noradrenaline terminals mediate the spinal antinociceptive effects of morphine in the periaqueductal gray. Brain Res. 160:180-185; 1979.
88. Yaksh, T. L. Spinal opiate analgesia: Characteristics and principles of action. Pain 11:293-346; 1981.
89. Yaksh, T. L. The effects of intrathecally administered opioid and adrenergic agents on spinal function. In: Yaksh, T. L., ed. Spinal afferent processing. New York: Plenum Press; 1986:505-539.
90. Yaksh, T. L. Pharmacology and mechanisms of opioid analgesic activity. Acta Anaesth. Scand. 41:94-111; 1997.
91. Yaksh, T. L.; Wilson, P. R. Spinal serotonin terminal system mediates antinociception. J. Pharmacol. Exp. Ther. 208:446-453; 1979.
92. Yamamoto, T.; Nozaki-Taguchi, N.; Kimura, S. Analgesic effect of intrathecally administered nociceptin, an opioid receptor-like 1 receptor agonist, in the rat formalin test. Neuroscience 81:249-254; 1977.
93. Yamamoto, T.; Yaksh, T. L. Stereospecific effects of a nonpeptidic NK1 selective antagonist, CP-96,345: Antinociception in the absence of motor dysfunction. Life Sci. 49:1955-1963; 1991.
94. Yasphal, K.; Radshakrishnan, V.; Coderre, T. J.; Henry, J. L. CP-96,345, but not its stereoisomer, CP-96,344, blocks the nociceptive responses to intrathecally administered substance P and to noxious thermal and chemical stimuli in the rat. Neuroscience 52:1839-1847; 1993.
95. Yukhananov, R. Y.; Handa, R. J. Effect of morphine on proenkephalin gene expression in the rat brain. Brain Res. Bull. 43:349-356; 1997.
96. Zemlan, F. P.; Behbehani, M. M.; Murphy, R. M. Serotonin receptor subtypes and the modulation of pain transmission. Prog. Brain Res. 77:349-355; 1988.
97. Zhang, C.; Yang, S. W.; Guo, Y. G.; Quiao, J. T.; Dafny, N. Locus coeruleus stimulation modulates the nociceptive response in parafascicular neurons: An analysis of descending and ascending pathways. Brain Res. Bull. 42:273-278; 1997.